EBS · Company research
Emergent Biosolutions, Inc. (EBS): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
20records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| $EBS stock is down 13% today. Here's what we see in our data. - Quiver Quantitative | $EBS stock is down 13% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Oct 16, 2026 | neutral | 0 | 0.6 |
| Emergent BioSolutions Inc. (EBS) stock price, news, quote and history - Yahoo Finance Singapore | Emergent BioSolutions Inc. (EBS) stock price, news, quote and history Yahoo Finance Singapore | View source ↗ | Yahoo Finance Singapore | Oct 16, 2026 | neutral | 0 | 0.6 |
| A retiring CFO will advise Emergent through March - Stock Titan | A retiring CFO will advise Emergent through March Stock Titan | View source ↗ | Stock Titan | Oct 16, 2026 | neutral | 0 | 0.6 |
| INO, MRNA, NVAX, EBS Jump Overnight: Trump Promises Full Hantavirus Report As Deadly Outbreak Sparks Vaccine Rally - Stocktwits | INO, MRNA, NVAX, EBS Jump Overnight: Trump Promises Full Hantavirus Report As Deadly Outbreak Sparks Vaccine Rally Stocktwits | View source ↗ | Stocktwits | Oct 16, 2026 | neutral | 0 | 0.6 |
| (EBS) Risk Channels and Responsive Allocation - Stock Traders Daily | (EBS) Risk Channels and Responsive Allocation Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 16, 2026 | neutral | 0 | 0.6 |
| A Nov. 2 call on third-quarter results from Emergent BioSolutions will be online and by phone. - Stock Titan | A Nov. 2 call on third-quarter results from Emergent BioSolutions will be online and by phone. Stock Titan | View source ↗ | Stock Titan | Oct 15, 2026 | neutral | 0 | 0.6 |
| Director Donald DeGolyer proposes selling 17,800 Emergent BioSolutions (NYSE: EBS) shares. - Stock Titan | Director Donald DeGolyer proposes selling 17,800 Emergent BioSolutions (NYSE: EBS) shares. Stock Titan | View source ↗ | Stock Titan | Oct 7, 2026 | neutral | 0 | 0.6 |
| To cover stock-award taxes, an Emergent BioSolutions (EBS) director sold 17,800 shares under a trading plan. - Stock Titan | To cover stock-award taxes, an Emergent BioSolutions (EBS) director sold 17,800 shares under a trading plan. Stock Titan | View source ↗ | Stock Titan | Oct 7, 2026 | neutral | 0 | 0.6 |
| Emergent BioSolutions Inc. (EBS) Stock Price, News, Quote & History - Yahoo! Finance Canada | Emergent BioSolutions Inc. (EBS) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 7, 2026 | neutral | 0 | 0.6 |
| Emergent BioSolutions Inc. (EBS) stock price, news, quote and history - Yahoo Finance UK | Emergent BioSolutions Inc. (EBS) stock price, news, quote and history Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 7, 2026 | neutral | 0 | 0.6 |
| Emergent Biosolutions (EBS) Soars 14.4%: Is Further Upside Left in the Stock? | Emergent Biosolutions stock jumped 14.4% following positive news including a $24 million BARDA contract for Cyfendus, a three-year Canadian government contract for Narcan nasal spray, and a $75 million debt repurchase. However, the company faces headwinds with expected quarterly losses of $0.37 per share and revenues declining 46.6% year-over-year. With unchanged earnings estimates and a Zacks Rank #3 (Hold) rating, analysts question whether the rally can sustain. | View source ↗ | Zacks Investment Research | Oct 6, 2026 | neutral | 0 | 1 |
| Emergent Biosolutions (EBS) Soars 14.4%: Is Further Upside Left in the Stock? | Emergent Biosolutions stock jumped 14.4% following positive news including a $24 million BARDA contract for Cyfendus, a three-year Canadian government contract for Narcan nasal spray, and a $75 million debt repurchase. However, the company faces headwinds with expected quarterly losses of $0.37 per share and revenues declining 46.6% year-over-year. With unchanged earnings estimates and a Zacks Rank #3 (Hold) rating, analysts question whether the rally can sustain. | View source ↗ | Zacks Investment Research | Oct 6, 2026 | neutral | 0 | 1 |
| Emergent Biosolutions (EBS) Soars 14.4%: Is Further Upside Left in the Stock? - Yahoo Finance | Emergent Biosolutions (EBS) Soars 14.4%: Is Further Upside Left in the Stock? Yahoo Finance | View source ↗ | Yahoo Finance | Oct 6, 2026 | neutral | 0 | 0.6 |
| Trading Systems Reacting to (EBS) Volatility - Stock Traders Daily | Trading Systems Reacting to (EBS) Volatility Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 5, 2026 | neutral | 0 | 0.6 |
| Emergent BioSolutions (NYSE:EBS) Stock Forecast & Analyst Predictions - Simply Wall Street | Emergent BioSolutions (NYSE:EBS) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Sep 9, 2026 | neutral | 0 | 0.6 |
| Emergent BioSolutions (EBS) Securities Investigation Notice - Levi & Korsinsky - PR Newswire | Emergent BioSolutions (EBS) Securities Investigation Notice - Levi & Korsinsky PR Newswire | View source ↗ | PR Newswire | Aug 17, 2026 | neutral | 0 | 0.6 |
| Why Did TTD, PZZA, EBS Stocks Plummet To 52 Week Lows? - TradingView | Why Did TTD, PZZA, EBS Stocks Plummet To 52 Week Lows? TradingView | View source ↗ | TradingView | Aug 11, 2026 | neutral | 0 | 0.6 |
| Emergent Bio stock slips despite Q2 beat (EBS:NYSE) - Seeking Alpha | Emergent Bio stock slips despite Q2 beat (EBS:NYSE) Seeking Alpha | View source ↗ | Seeking Alpha | Aug 6, 2026 | neutral | 0 | 0.6 |
| $EBS stock is down 32% today. Here's what we see in our data. - Quiver Quantitative | $EBS stock is down 32% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 6, 2026 | neutral | 0 | 0.6 |
| Emergent BioSolutions (EBS) Stock Rises on Q1 2026 Earnings - Quiver Quantitative | Emergent BioSolutions (EBS) Stock Rises on Q1 2026 Earnings Quiver Quantitative | View source ↗ | Quiver Quantitative | Apr 30, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.